Filing Flows › Syra Health (SYRA) › Q4 2025
Syra Health (SYRA) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 12, 2026
Syra Health (SYRA) reported revenue of $1.7M for the fourth quarter 2025 (Q4 2025), -14% from a year earlier and +3% from the quarter before. Operating margin was -7.8%, net loss $135K (7.8% of revenue).
Syra Health, Q4 2025: revenue $1.7M (-14% year over year), operating margin -7.8%, net loss $135K, operating cash flow −$289K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | +3% | -14% |
| Operating profit | −$136K | — | — |
| Net earnings | −$135K | — | — |
| Operating cash flow | −$289K | — | — |
What changed
Revenue was $1.7M in Q4 2025, down 14% year over year and up 3% from the previous quarter. Population Health was the largest line at 72% of revenue.
Gross margin was 34.1%, up 17.4 points from a year earlier. Operating costs exceeded revenue by $136K, an operating margin of -7.8%. Operating expenses fell 13% while revenue fell 14%. The fastest-growing cost line was SG&A (+33%). The quarter ended with a net loss of $135K, narrower than the previous quarter's $226K loss.
Operating cash flow was −$289K. Non-cash charges added back $2K of depreciation and $23K of share-based compensation. Working capital and other items used $180K.
Questions
What was Syra Health's revenue in the fourth quarter 2025?
Syra Health (SYRA) reported revenue of $1.7M for the fourth quarter 2025 (Q4 2025), -14% from a year earlier and +3% from the quarter before.
Was Syra Health profitable in the fourth quarter 2025?
Operating loss was $136K (-7.8% of revenue) and net loss $135K.
Source: Syra Health 10-K on SEC EDGAR.